6:8 Medical Solutions and CTOMS to Bring Popp Point Pressure Device (P3D) Family to Canadian Markets
6:8 Medical Solutions and CTOMS are proud to announce a new strategic partnership that will bring the Popp Point Pressure Device (P3D) Family to Canadian markets for the first time.
This partnership unites two companies founded and led by military veterans of the Global War on Terror (GWOT)—leaders who have translated battlefield lessons into life-saving innovations and training.
“This is more than a business deal—it’s a mission alignment,” said Uriah Popp, CEO of 6:8 Medical Solutions. “At 6:8, we design trauma solutions born out of necessity and experience. CTOMS is the ideal partner to deliver our P3D Family to Canadian medics and operators who need the best tools possible when lives are on the line.”
Christopher Kopp, CEO of CTOMS, added: “The P3D Family offers an innovative approach to hemorrhage management that fills critical gaps in casualty care. We’re proud to bring these devices to Canadian professionals who serve in high-threat environments as well as those who support and provide emergency services in Canada.”
The Popp Point Pressure Device Family includes the Advantage Targeted Pressure Bar and the Hemguard Bandage—two field-tested tools designed for rapid, reliable control of compressible hemorrhage. These devices offer focused mechanical pressure exactly where it’s needed, enhancing the effectiveness and offering a solution to difficult to bandage sites on the body.
Under this agreement, CTOMS will serve as the exclusive Canadian distributor of the P3D Family, as well as the other medical devices coming to market from 6:8 integrating them into its comprehensive lineup of tactical medical solutions for military, law enforcement, and prehospital emergency services.
Together, 6:8 Medical Solutions and CTOMS are reshaping the tactical medical landscape—providing cutting-edge solutions to the people who need them most.
You can skip to the end and leave a response. Pinging is currently not allowed.
Read the full article here
